Journal List > J Korean Med Assoc > v.53(2) > 1042242

Kim: Cancer Pain Management-Nonopoid Analgesics

Abstract

Cancer pain patients have various diagnosis, stage of disease, response to pain, and treatments and individualized treatment methods are thus needed. Use of Nonopioid analgesics is the first step treatment (according to WHO ladder) for mild to moderate pain, and may be useful for second or third step treatments when combined with weak or strong opioids to reduce side effects of opioids and to create synergy between the two drugs. Acetaminophen and nonsteroidal antiinflammatory drugs(NSAIDs) are also nonopioid analgesics. NSAIDs have a ceiling effect, along with antipyretic, analgesic and antiinflammatory effects, while not producing physical and psychological dependence. Adverse effects of NSAIDs include gastrointestinal hemorrhage, coagulopathy, and deterioration of renal function.

Figures and Tables

Table 1
Nonsteroidal Antiinflammatory Drugs (NSAIDs)
jkma-53-164-i001
Table 2
Side Effects of NSAIDs
jkma-53-164-i002

CNS: central nerve system, COX- 2: cyclooxygenase-2, NSAIDs: nonsteroidal anti-inflammatory drugs

References

1. The korean pain society. Pain Medicine. 2007. 3rd ed. Seoul: Koonja Publishing;425–442.
2. Parris WCV, Eriator I. Smith HS, editor. Cancer pain management. Current theapy in pain. 2009. Philadelphia: Saunders Elsevier;97–106.
crossref
3. Kim MJ, Park JA, Shin SJ. Pain and pain management in hospitalized cancer patients. J Korean Acad Fundam Nurs. 2008. 15:161–170.
4. Heo DS. Pharmacologic management of cancer pain. J Korean Med Assoc. 2004. 47:268–276.
crossref
5. Baik SW, Byeun BM, Chae MG. The clinical evaluation in cancer pain management. Korean J Pain. 1998. 11:214–219.
TOOLS
Similar articles